Our clinical analyses revealed tumor-specific expression patterns: E-cadherin is upregulated in breast cancer samples but significantly downregulated in melanoma samples, suggesting context-dependent roles (Supplemental Figure 7A). The gene discussed is CDH1; the disease is breast carcinoma.